Torrent Pharmaceuticals Ltd. Is based in Ahmedabad in India and established in 1959.It was initially promoted as Trinity Laboratories by U.N Mehta and was later known as Torrent Pharmaceuticals.
It is the top player in therapeutic areas of CNS(Central Nervous System) and CV(Cardiovascular) and has significant presence inGastro-intestinal, Diabetology and Anti-effective management systems. Torrent currently operates in more than 40 countries with over 1200 products registered globally.
Torrent has seven fully owned subsidiaries in Germany, Brazil, Russia, US, Philippines as well as Canada.
Torrent Pharma with its niche marketing right from the start and being the company with most number of First launches ensured that it is always ahead of the competition. It also entered therapeutic segments of oncology and nephrology.
Torrent Pharma is now looking for more collaborations and marketing of its products to become the most competitive company worldwide. It has all the technical capabilities, cost advantages, International accreditations as well as global reach.
Torrent Pharma has earned many awards and accolades including the “Export Excellence Awards” bestowed by the government of India. It is the sole manufacturer of Insulin Formulations since 1990’s for Novo Nordisk with dedicated packaging facility for Insulin.
It has world class manufacturing facilities in India situated in Gujarat, Himanchal Pradesh and Sikkim. Torrent is one of the few pharma companies which realized the importance of R&D and so it heavily invests here with this year expenses amounting to around 210 crores to work effectively on drug discovery and development projects.
Torrent Pharma has also acquired the branded formulations of Elder Pharmaceuticals in Nepal and India and thus expanded its already wide portfolio of Products.